CD1-HM355-100μg / 询价
CD1-HM355-500μg / 询价
CD1-HM355-500μgx2 / 询价
Human CD155/PVR Protein
Recombinant Human CD155/PVR Protein is expressed from HEK293 with mFc (IgG1) tag at the C-Terminus.It contains Trp21-Asn343 [Accession | P15151-1].
The protein has a predicted MW of 61.3 kDa. Due to glycosylation, the protein migrates to 75-100 kDa based on Bis-Tris PAGE result.
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Less than 1EU per μg by the LAL method.
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3 months after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Human CD155 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human CD155 is greater than 95% as determined by SEC-HPLC.
Immobilized Human CD155, mFc Tag at 2μg/ml (100μl/well) on the plate. Dose response curve for Human TIGIT, hFc Tag with the EC50 of 0.13μg/ml determined by ELISA (QC Test).
Immobilized Human DNAM-1, His Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Human CD155, mFc Tag with the EC50 of 0.16μg/ml determined by ELISA.
CD155 is a cell surface adhesion molecule functioning in tumor cell migration, invasion, and metastasis, and not surprisingly, is also designated as a common tumor-associated antigen. CD155 is also recognized by NK cells to induce their cytotoxicity. CD155 is also commonly referred to as the "poliovirus receptor," or PVR.
CD155; HVED; NECL5; Necl-5; nectin-like 5; PVR; PVS; Tage4; PVSFLJ25946; FLJ25946
(1)Yu X , Harden K , C Gonzalez L , et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells[J]. NATURE IMMUNOLOGY, 2008, 10(1):48-57.
